The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy
Open accessAbstract
Previous studies from our group, focusing on neuro-glial remodelling in human temporal lobe epilepsy (TLE), have shown the presence of immature vascular cells in various areas of the hippocampus. Here, we investigated angiogenic processes in hippocampi surgically removed from adult patients suffering from chronic intractable TLE, with various aetiologies. We compared hippocampi from TLE patients to hippocampi obtained after surgery or autopsy from non-epileptic patients (NE). We quantified the vascular density, checked for the expression of angiogenic factors and their receptors and looked for any blood-brain barrier (BBB) leakage. We used a relevant model of rat limbic epilepsy, induced by lithium-pilocarpine treatment, to understand the sequence of events. In humans, the vessel density was significantly higher in TLE than in NE patients. This was neither dependent on the aetiology nor on the degree of neuronal loss, but was positively correlated with seizure frequency. In the whole hippocampus, we observed many complex, tortuous microvessels. In the dentate gyrus, when the granular layer was dispersed, long microvessels appeared radially orientated. Vascular endothelial factor (VEGF) and tyrosine kinase receptors were detected in different types of cells. An impairment of the BBB was demonstrated by the loss of tight junctions and by Immunoglobulines G (IgG) leakage and accumulation in neurons. In the rat model of TLE, VEGF over-expression and BBB impairment occurred early after status epilepticus, followed by a progressive increase in vascularization. In humans and rodents, angiogenic processes and BBB disruption were still obvious in the chronic focus, probably activated by recurrent seizures. We suggest that the persistent leakage of serum IgG in the interstitial space and their uptake by neurons may participate in hypoperfusion and in neuronal dysfunction occurring in TLE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“BBB dysfunction positively correlates with seizure frequency and is independent of neuronal loss (234, 499).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [499]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Increased microvascular density, loss of tight junctions, and IgG leakage are observed in hippocampal resections from humans with temporal lobe epilepsy (499), and are also observed in rodent epileptic models (145, 499).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [499]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brain Inflammation in Epilepsy: Experimental and Clinical Evidence
Vezzani, A., & Granata, T. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00298.x · Cited by 1,049
Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy
van Vliet, E. A., da Costa Araujo, S., Redeker, S., van Schaik, R., Aronica, E., & Gorter, J. A. (2007) · Brain · doi:10.1093/brain/awl318 · Cited by 775
Turski, L., Ikonomidou, C., Turski, W. A., Bortolotto, Z. A., & Cavalheiro, É. A. (1989) · Synapse · doi:10.1002/syn.890030207 · Cited by 626
TGF- receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis
Ivens, S., Kaufer, D., Flores, L. P., Bechmann, I., Zumsteg, D., Tomkins, O., Seiffert, E., Heinemann, U., & Friedman, A. (2007) · Brain · doi:10.1093/brain/awl317 · Cited by 567
Mesial Temporal Lobe Epilepsy: What Have We Learned?
Engel, J. (2001) · The Neuroscientist · doi:10.1177/107385840100700410 · Cited by 558
Lasting Blood-Brain Barrier Disruption Induces Epileptic Focus in the Rat Somatosensory Cortex
Seiffert, E., Dreier, J. P., Ivens, S., Bechmann, I., Tomkins‐Netzer, O., Heinemann, U., & Friedman, A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1751-04.2004 · Cited by 518
Expression of hypoxia-inducible factor 1: mechanisms and consequences
Semenza, G. L. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00292-0 · Cited by 517
Ozawa, C. R., Banfi, A., Glazer, N. L., Thurston, G., Springer, M. L., Kraft, P. E., McDonald, D. M., & Blau, H. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18420 · Cited by 517
VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection
Storkebaum, E., Lambrechts, D., & Carmeliet, P. (2004) · BioEssays · doi:10.1002/bies.20092 · Cited by 505
Duncan, J. S. (1997) · Brain · doi:10.1093/brain/120.2.339 · Cited by 462
Flagged first, then by citations
Research works printed but not linked: 1
- Spielmeyer W. Die Pathogenese des epileptisches Krampfes, histopatholo- gischer Teil. Ztschr Neurol Psychiatr 1927; 109: 501-19.
Cited by
Sorted by citations
Items 201–300 of 429
Sun, F., Wei, Y., Li, S., Guo, W., Chen, X., Liu, S., He, J., Yin, Q., Yang, H., & Zhang, C. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0714-y · Cited by 29
Glia–Neuron Interactions in Ictogenesis and Epileptogenesis
Vezzani, A., Auvin, S., Ravizza, T., & Aronica, E. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.003.0048 · Cited by 29
Löscher, W. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_406 · Cited by 33
Wang, W., Wang, L., Luo, J., Xi, Z., Wang, X., Chen, G., & Chu, L. (2012) · Neurochemical Research · doi:10.1007/s11064-011-0677-x · Cited by 29
Epileptic Focus and Alteration of Metabolism
Otáhal, J., Folbergrová, J., Kovacs, R., Kunz, W. S., & Maggio, N. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-418693-4.00009-1 · Cited by 29
Histopathology of Human Epilepsy
de Lanerolle, N. C., Lee, T.-S. W., & Spencer, D. D. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.003.0030 · Cited by 29
Keren-Aviram, G., Dachet, F., Bagla, S., Balan, K., Loeb, J. A., & Dratz, E. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195639 · Cited by 28
Proteomic signature of the Dravet syndrome in the genetic Scn1a-A1783V mouse model
Miljanovic, N., Hauck, S. M., van Dijk, R. M., Liberto, V. D., Rezaei, A., & Potschka, H. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105423 · Cited by 28
Fahoum, F., & Eyal, S. (2023) · Epilepsia · doi:10.1111/epi.17625 · Cited by 27
Hong, Y., Wei, C., Fu, M., Li, X., Zhang, H., & Yao, B. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111236 · Cited by 28
Evolution of the VEGF-Regulated Vascular Network from a Neural Guidance System
Ponnambalam, S., & Alberghina, M. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8167-3 · Cited by 26
The neurovascular extracellular matrix in health and disease
Logsdon, A. F., Rhea, E. M., Reed, M. J., Banks, W. A., & Erickson, M. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220977195 · Cited by 28
Changes in serum blood-brain barrier markers after bilateral tonic-clonic seizures
Cudna, A., Bronisz, E., Jopowicz, A., & Kurkowska‐Jastrzębska, I. (2023) · Seizure · doi:10.1016/j.seizure.2023.02.012 · Cited by 28
Cammalleri, M., Martini, D., Ristori, C., Timperio, A. M., & Bagnoli, P. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07529.x · Cited by 26
Lü, Y., Xue, T., Yuan, J., Li, Y., Wu, Y., Xi, Z., Xiao, Z., Chen, Y., & Wang, X. (2008) · Clinical Science · doi:10.1042/cs20080347 · Cited by 26
Tetranectin is a potential biomarker in cerebrospinal fluid and serum of patients with epilepsy
Wang, L., Pan, Y., Chen, D., Xiao, Z., Xi, Z., Xiao, F., & Wang, X. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.01.022 · Cited by 26
Sildenafil Improves Brain Injury Recovery following Term Neonatal Hypoxia-Ischemia in Male Rat Pups
Yazdani, A., Khoja, Z., Johnstone, A. D., Dale, L., Rampakakis, E., & Wintermark, P. (2016) · Developmental Neuroscience · doi:10.1159/000448327 · Cited by 26
Cellular responses to recurrent pentylenetetrazole-induced seizures in the adult zebrafish brain
Duy, P. Q., Berberoglu, M. A., Beattie, C. E., & Hall, C. W. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.02.032 · Cited by 26
Kim, J., & Kang, T. (2017) · Brain Research · doi:10.1016/j.brainres.2017.07.020 · Cited by 25
Shankar, R., Newman, C. G. J., Gales, A., McLean, B., Hanna, J., Ashby, S., Walker, M. C., & Sander, J. W. A. S. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00281 · Cited by 25
An iPSC-Derived Neuron Model of CLN3 Disease Facilitates Small Molecule Phenotypic Screening
Kinarivala, N., Morsy, A., Patel, R., Carmona, A. V., Sajib, M. S., Raut, S., Mikelis, C. M., Al-Ahmad, A. J., & Trippier, P. C. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00077 · Cited by 25
Bernardino, P. N., Luo, A., Andrew, P. M., Crowe, C. M., González, M. I., Gelli, A., & Lein, P. J. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001836 · Cited by 27
Zhai, X., Liang, P., Li, Y., Li, L., Zhou, Y., Wu, X., Deng, J., & Jiang, L. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9492-8 · Cited by 26
Li, H.-P., Liu, X., Wang, R., Lu, A.-L., Ma, Z., Wu, S., Lu, H.-J., Du, Y., Deng, K., Wang, L.-X., et al. (2023) · Epilepsia · doi:10.1111/epi.17576 · Cited by 23
Intracellular and circulating neuronal antinuclear antibodies in human epilepsy
Iffland, P. H., Tavares, J. C., Trigunaite, A., Man, S., Rasmussen, P. A., Alexopoulos, A. V., Ghosh, C., Jørgensen, T. N., & Janigro, D. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.07.006 · Cited by 23
Li, Y., Chen, J., Zeng, T.-F., Lei, D., Chen, L., & Zhou, D. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1681-0 · Cited by 24
Clinical and Genetic Aspects of Epilepsy
Heron, S., & Mulley, J. (2011) · InTech eBooks · doi:10.5772/1138 · Cited by 24
Glibenclamide ameliorates cerebral edema and improves outcomes in a rat model of status epilepticus
Lin, Z., Huang, H., Gu, Y., Huang, K., Hu, Y., Ji, Z., Wu, Y., Wang, S., Yang, T., & Pan, S. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.016 · Cited by 24
Thom, M., & Bertram, E. H. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52898-8.00014-8 · Cited by 24
Peptide fragment of thymosin β4 increases hippocampal neurogenesis and facilitates spatial memory
Kim, D.-Y., Moon, E., Yi, J. H., Lee, H., Park, S. J., Ryu, Y., Kim, H.-C., Lee, S., & Ryu, J. H. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.09.017 · Cited by 23
VEGF Receptor-2 (Flk-1) Overexpression in Mice Counteracts Focal Epileptic Seizures
Nikitidou, L., Kanter‐Schlifke, I., Dhondt, J., Carmeliet, P., Lambrechts, D., & Kokaia, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040535 · Cited by 23
Chip, S., Nitsch, C., Wellmann, S. M., & Kapfhammer, J. P. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.190 · Cited by 23
Disease-modifying effect of intravenous immunoglobulin in an experimental model of epilepsy
Chen, M., Arumugam, T. V., Leanage, G., Tieng, Q. M., Yadav, A., Ullmann, J. F. P., She, D. T., Truong, V., Ruitenberg, M. J., & Reutens, D. C. (2017) · Scientific Reports · doi:10.1038/srep40528 · Cited by 23
Unveiling the hidden connection: the blood-brain barrier’s role in epilepsy
Han, J., Wang, Y., Wei, P., Lu, D., & Shan, Y. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1413023 · Cited by 25
The Role of Blood–Brain Barrier Disruption in Epilepsy: Mechanisms and Consequences
Suleymanova, E. M., & Karan, A. A. (2025) · Neurology International · doi:10.3390/neurolint18010001 · Cited by 23
Commonly Overlooked Factors in Biocompatibility Studies of Neural Implants
Kumosa, L. S. (2023) · Advanced Science · doi:10.1002/advs.202205095 · Cited by 21
Ngo, A., Royer, J., Rodríguez‐Cruces, R., Xie, K., DeKraker, J., Auer, H., Tavakol, S., Lam, J., Schrader, D. V., Dudley, R., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209528 · Cited by 22
Suzuki, Y., Nagai, N., & Umemura, K. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10r27fm · Cited by 22
P2Y4/TSP-1/TGF-β1/pSmad2/3 pathway contributes to acute generalized seizures induced by kainic acid
Zhang, Y., Zhu, W., Yu, H., Yu, J., Zhang, M., Pan, X., Gao, X. J., Wang, Q., & Sun, H. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.04.004 · Cited by 22
Contributions of Drug Transporters to Blood-Brain Barriers
Liu, L., & Liu, X. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7647-4_9 · Cited by 21
Involvement of vascular endothelial growth factor in schizophrenia
Rampino, A., Annese, T., Torretta, S., Tamma, R., Falcone, R. M., & Ribatti, D. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136093 · Cited by 21
Han, W., Jiang, L., Song, X., Li, T., Chen, H., & Cheng, L. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.808568 · Cited by 22
LYL1 activity is required for the maturation of newly formed blood vessels in adulthood
Pirot, N., Deleuze, V., El-Hajj, R., Dohet, C., Sablitzky, F., Couttet, P., Mathieu-Mahul, D., & Pinet, V. (2010) · Blood · doi:10.1182/blood-2010-03-275651 · Cited by 23
The blood–brain barrier as a treatment target for neurodegenerative disorders
Rust, R., Sagare, A. P., Zhang, M., Zloković, B. V., & Kisler, K. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2480654 · Cited by 21
Castro-Torres, R. D., Ureña‐Guerrero, M. E., Chacón, L. M. M., Pedré, L. L., Estupiñán-Díaz, B., Rocha, L., Orozco-Suárez, S. A., Rivera-Cervantes, M. C., Alonso‐Vanegas, M., & Beas‐Zárate, C. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01519-6 · Cited by 20
He, J., Sun, F., Wang, Y., Luo, X., Peng, L., Zhou, J., Zhu, D., Li, Z., & Yang, H. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.07.017 · Cited by 21
Fan, Y., & Liu, X. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030102 · Cited by 20
Eyndhoven, S. V., Dupont, P. J., Tousseyn, S., Vervliet, N., Paesschen, W. V., Huffel, S. V., & Hunyadi, B. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117652 · Cited by 20
Huang, J.-B., Hsu, S., Pan, H.-Y., Chen, S., Chen, S., Lin, T., Liu, X.-P., Li, J.-H., Chen, N.-C., Liou, C., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197247 · Cited by 20
Goasdoué, K., Chand, K. K., Miller, S. M., Lee, K. M., Colditz, P. B., Wixey, J. A., & Bjorkman, S. T. (2018) · Developmental Neuroscience · doi:10.1159/000499365 · Cited by 19
Alonso‐Nanclares, L., & DeFelipe, J. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.12.009 · Cited by 19
Zheng, Y., Jin, M., Suo, G., Wu, Y., Sun, Y., & Ni, H. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.562853 · Cited by 19
Microangiopathy in temporal lobe epilepsy with diffusion MRI alterations and cognitive decline
Liu, J. Y. W., Binding, L., Puntambekar, I., Patodia, S., Lim, Y. M., Mryzyglod, A., Xiao, F., Pan, S.-N., Mito, R., de Tisi, J., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02809-8 · Cited by 15
What Is the Clinical Relevance of In Vitro Epileptiform Activity?
Heinemann, U., & Staley, K. J. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-8914-1_2 · Cited by 18
Lahtinen, L., Ndode‐Ekane, X. E., Barinka, F., Akamine, Y., Esmaeili, M. H., Rantala, J., & Pitkänen, A. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.008 · Cited by 18
Reduced Ratio of Afferent to Total Vascular Density in Mesial Temporal Sclerosis
Mott, R. T., Thore, C. R., Moody, D. M., Glazier, S. S., Ellis, T. L., & Brown, W. R. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181b9d75f · Cited by 18
Blood-Brain Barrier Breakdown and Blood-Brain Communication in Neurological and Psychiatric Diseases
Friedman, A., & Kaufer, D. (2011) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2011/431470 · Cited by 18
The Breakdown of Neurovascular Barriers: Molecular Mechanisms of Tight Junction Dysfunction
Gopal, S. S., Kaur, M., Lanzkron, S., & Srivastava, A. K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05592-z · Cited by 20
Song, Y., Riera, J. J., Bhatia, S., Ragheb, J. R., Garcia, C., Weil, A. G., Jayakar, P., & Lin, W. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.02.015 · Cited by 17
Meabon, J. S., Cook, D. G., Yagi, M., Terry, G. E., Cross, D. J., Muzi, M., Pagulayan, K. F., Logsdon, A. F., Schindler, A. G., Ghai, V., et al. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117049 · Cited by 17
Zhang, C., Shu, H., Yin, Q., An, N., Xu, S., Yin, J., Song, Y., Liu, S., & Yang, H. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00519.x · Cited by 17
Over-expression of laminin correlates to recovery of vasogenic edema following status epilepticus
Kim, Y.-J., Kim, J.-Y., Ko, A.-R., & Kang, T.-C. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.06.005 · Cited by 17
Hakvoort, K., Otto, L., Haeren, R. H. L., Hoogland, G., Schijns, O. E. M. G., Vink, H., Klein, D. C. G., van Zandvoort, M. A. M. J., & Rijkers, K. (2020) · The Journal of Comparative Neurology · doi:10.1002/cne.24971 · Cited by 16
Faissner, A. (2023) · Frontiers in Network Physiology · doi:10.3389/fnetp.2023.1190240 · Cited by 17
Evidence for interictal blood–brain barrier dysfunction in people with epilepsy
Reiter, J. T., Schulte, F., Bauer, T., David, B., Endler, C., Isaak, A., Schuch, F., Bitzer, F., Witt, J., Hattingen, E., et al. (2024) · Epilepsia · doi:10.1111/epi.17929 · Cited by 16
Brain-targeted nanoparticles to overcome the blood-brain barrier
Seko, I., ŞAHİN, A., Tonbul, H., & Çapan, Y. (2020) · Journal of Pharmaceutical Technolgy · doi:10.37662/jpt.2020.4 · Cited by 16
VEGF as a Target for Neuroprotection
Vezzani, A. (2008) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7511.2008.00269.x · Cited by 16
Cerebral aquaporin-4 expression is independent of seizures in tuberous sclerosis complex
Short, B., Klofas, L. K., Harmsen, H. J., Zhang, B., Wong, M. L., Ess, K. C., Fu, C., Naftel, R. P., Pearson, M. M., & Carson, R. P. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.05.003 · Cited by 15
Özkara, Ç., & Aronica, E. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52899-5.00019-8 · Cited by 15
Ping, S., Qiu, X., Gonzalez-Toledo, M. E., Liu, X., & Zhao, L. (2018) · Cell Transplantation · doi:10.1177/0963689718766460 · Cited by 15
Gu, P., Xu, Z., Cao, Y., Liao, S., Deng, Q.-F., Yin, X., Wang, Z., Chen, Z., Hu, X., Wang, H., et al. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00450-0 · Cited by 15
Henning, L., Steinhäuser, C., & Bedner, P. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.660591 · Cited by 15
Mann, A., Billington, S. F., Benifla, M., Nguyen, T. B., Han, H., Bennet-Back, O., Gilboa, T., Blatch, D., Fellig, Y., Volkov, O., et al. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00083 · Cited by 15
Ceccariglia, S., D’Altocolle, A., Fà, A. D., Silvestrini, A., Barba, M., Pizzolante, F., Repele, A., Michetti, F., & Gangitano, C. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.047 · Cited by 15
Concentration of Soluble Adhesion Molecules in Cerebrospinal Fluid and Serum of Epilepsy Patients
Luo, J., Wang, W., Xi, Z., Chen, D., Wang, L., Xiao, Z., & Wang, X. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0366-8 · Cited by 15
Kim, J. H., Choi, B. Y., Kho, A. R., Lee, S.-B., Jeong, J. H., Hong, D. K., Lee, S.-B., Sohn, M., Ryu, O., Choi, M. ‐., et al. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12567 · Cited by 15
Boux, F., Forbes, F., Collomb, N., Zub, E., Mazière, L., de Bock, F., Blaquière, M., Stupar, V., Depaulis, A., Marchi, N., et al. (2021) · Epilepsia · doi:10.1111/epi.16886 · Cited by 15
IL-17A Aggravated Blood–Brain Barrier Disruption via Activating Src Signaling in Epilepsy Mice
Wang, J., Wu, T., Zhao, Y., Mao, L., Ding, J., & Wang, X. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04203-7 · Cited by 14
Сергеевич, А. А., Ryazanova, M. V., Baranich, T. I., Stavrovskaya, A. V., Rozanova, N. A., Novikova, S. V., & Salmina, A. B. (2023) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-023-05859-2 · Cited by 14
Kim, J. H., Lee, D. W., Choi, B. Y., Sohn, M., Lee, S. H., Choi, H., Song, H. K., & Suh, S. W. (2014) · Brain Research · doi:10.1016/j.brainres.2014.11.011 · Cited by 14
Kim, M.-J., Park, H., Choi, S.-H., Kong, M.-J., Kim, J.-E., & Kang, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194862 · Cited by 14
Hamed, R., Eyal, A. D., Berman, E., & Eyal, S. (2022) · Epilepsia · doi:10.1111/epi.17479 · Cited by 13
Ahn, J. H., Chen, B. H., Park, J. H., Shin, B. N., Lee, T.-K., Cho, J.-H., Lee, J. C., Park, J.-R., Yang, S., Ryoo, S., et al. (2018) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2692 · Cited by 15
Feldman, R. E., Marcuse, L. V., Verma, G., Brown, S. S. G., Rus, A., Rutland, J. W., Delman, B. N., Balchandani, P., & Fields, M. C. (2020) · Epilepsia · doi:10.1111/epi.16433 · Cited by 13
Golmohammadi, R., Pejhan, A., Azhdari‐Zarmehri, H., & Mohammad‐Zadeh, M. (2012) · Neurological Sciences · doi:10.1007/s10072-012-1190-y · Cited by 13
Kim, D., Min, S.-J., Kim, M.-J., Kim, J., & Kang, T. (2016) · Brain Research · doi:10.1016/j.brainres.2016.09.023 · Cited by 13
Sakurai, M., MORITA, T., Takeuchi, T., & Shimada, A. (2013) · American Journal of Veterinary Research · doi:10.2460/ajvr.74.5.763 · Cited by 13
Feng, L., Shu, Y., Wu, Q., Liu, T., Long, H., Yang, H., Li, Y., & Xiao, B. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.6017 · Cited by 14
van Lanen, R. H. G. J., Haeren, R. H. L., Staals, J., Dings, J. T. A., Schijns, O. E. M. G., Hoogland, G., van Kuijk, S. M. J., Kapsokalyvas, D., van Zandvoort, M. A. M. J., Vink, H., et al. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231179413 · Cited by 12
Sanches, E. F., van de Looij, Y., Toulotte, A., da Silva, A. R., Romero, J. A., & Sizonenko, S. V. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00480 · Cited by 12
Kim, Y.-J., Kim, J.-E., Choi, H., Song, H., & Kang, T. (2015) · BMB Reports · doi:10.5483/bmbrep.2015.48.6.237 · Cited by 11
Alinaghipour, A., Salami, M., & Nabavizadeh, F. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113975 · Cited by 11
Williams, S., Hossain, M., Mishra, S., Gonzalez-Martinez, J. A., Najm, I., & Ghosh, C. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1415-z · Cited by 11
Talin 2 concentrations in cerebrospinal fluid in patients with epilepsy
Xiao, Z., Shen, L., Chen, D., Wang, L., Xi, Z., Xiao, F., & Wang, X. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.06.015 · Cited by 12
Novel technologies for antiangiogenic drug delivery in the brain
Benny, O., & Pakneshan, P. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.2.7766 · Cited by 11
Activated protein C in epilepsy pathophysiology
Zoungrana, L. I., Didik, S., Wang, H., Slotabec, L. A., & Li, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1251017 · Cited by 11
The Application of Ultrasound‐Induced Blood–Brain Barrier Opening in Neurology and Immunology
Jiang, A., Wang, Z., Song, D., Zhang, X., Guan, M., Li, X., Tan, J., He, Y., Han, W., Ding, X., et al. (2025) · Small · doi:10.1002/smll.202502699 · Cited by 9
Guan, Z., Liu, Q., Wang, Y., Xiao, F., & Zhao, G. (2024) · Medicine Plus · doi:10.1016/j.medp.2024.100047 · Cited by 9
Vuong, J., Henderson, A., Tuor, U. I., Dunn, J. F., & Teskey, G. C. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03317.x · Cited by 9
Role of Proangiogenic Factors in Immunopathogenesis of Multiple Sclerosis.
Hamid, K. M., & Mirshafiey, A. (2016) · PubMed · Cited by 9
Metadata
- Authors
- Rigau, V., Morin, M., Rousset, M.-C., de Bock, F., Lebrun, A., Coubes, P., Picot, M.-C., Baldy-Moulinier, M., Bockaert, J., Crespel, A., & Lerner-Natoli, M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-05-29
- Volume
- 130
- Issue
- 7
- Pages
- 1942-1956
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2109644106
- Cited by
- 429
- References
- 53
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 18 · 2023: 13 · 2022: 17 · 2021: 17 · 2020: 35 · 2019: 19 · 2018: 23 · 2017: 23 · 2016: 26 · 2015: 22 · 2014: 32 · 2013: 24 · 2012: 37
- FWCI
- 14.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- temporal lobe epilepsy, angiogenesis, blood-brain barrier permeability, hippocampus, vascular endothelial growth factor, receptor tyrosine kinase, tight junctions, vessel density, dentate gyrus, status epilepticus, lithium-pilocarpine model, limbic epilepsy, hypoperfusion, neuronal dysfunction, seizure frequency
- MeSH terms
- Adolescent, Adult, Animals, Blood-Brain Barrier, Brain, Child, Disease Models, Animal, Epilepsy, Temporal Lobe, Female, Hippocampus, Humans, Male, Middle Aged, Neovascularization, Pathologic, Neurons, Permeability, Cell Death, Rats, Sprague-Dawley, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Receptor, TIE-2, Angiogenesis Inducing Agents, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review